The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 41, 2014, Pages 14924-14929

  Inloes, Jordon M ^a   Hsu, Ku Lung ^a   Dix, Melissa M ^a   Viader, Andreu ^a   Masuda, Kim ^a   Takei, Thais ^a   Wood, Malcolm R ^a   Cravatt, Benjamin F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DDHD2 PROTEIN, MOUSE; ENZYME INHIBITOR; FAT DROPLET; PHOSPHOLIPASE A1; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; C57BL MOUSE; CHEMISTRY; COGNITION; DEFICIENCY; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENE DELETION; GENE TARGETING; GENETICS; HEK293 CELL LINE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LOCOMOTION; METABOLISM; NERVE CELL; REPRODUCIBILITY; ULTRASTRUCTURE;

ANIMALS; BRAIN; COGNITION; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE DELETION; GENE TARGETING; HEK293 CELLS; HUMANS; LIPASE; LIPID DROPLETS; LOCOMOTION; MICE, INBRED C57BL; NEURONS; PHOSPHOLIPASES A1; REPRODUCIBILITY OF RESULTS; SPASTIC PARAPLEGIA, HEREDITARY; TRIGLYCERIDES;

EID: 84907892277     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1413706111     Document Type: Article

References (37)

1. Rabbani B, Mahdieh N, Hosomichi K, Nakaoka H, Inoue I (2012) Next-generation sequencing: Impact of exome sequencing in characterizing Mendelian disorders. J Hum Genet 57(10):621-632.
2. Fink JK (2013) Hereditary spastic paraplegia: Clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126(3):307-328.
3. Novarino G, et al. (2014) Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 343(6170):506-511.
4. Rainier S, et al. (2008) Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet 82(3):780-785.
5. Tesson C, et al. (2012) Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet 91(6): 1051-1064.
6. Schuurs-Hoeijmakers JH, et al.; FORGE Canada Consortium (2012) Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. Am J Hum Genet 91(6):1073-1081.
7. Gonzalez M, et al. (2013) Mutations in phospholipase DDHD2 cause autosomal recessive hereditary spastic paraplegia (SPG54). Eur J Hum Genet 21(11):1214-1218.
8. Citterio A, et al. (2014) Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis. J Neurol 261(2):373-381.
9. Nakajima K, et al. (2002) A novel phospholipase A1 with sequence homology to a mammalian Sec23p-interacting protein, p125. J Biol Chem 277(13):11329-11335.
10. Higgs HN, Han MH, Johnson GE, Glomset JA (1998) Cloning of a phosphatidic acid-preferring phospholipase A1 from bovine testis. J Biol Chem 273(10):5468-5477.
11. van Tienhoven M, Atkins J, Li Y, Glynn P (2002) Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J Biol Chem 277(23):20942-20948.
12. Gross RW, Han X (2011) Lipidomics at the interface of structure and function in systems biology. Chem Biol 18(3):284-291.
13. Saghatelian A, et al. (2004) Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43(45):14332-14339.
14. Simon GM, Cravatt BF (2010) Activity-based proteomics of enzyme superfamilies: Serine hydrolases as a case study. J Biol Chem 285(15):11051-11055.
15. Wilson-Grady JT, Haas W, Gygi SP (2013) Quantitative comparison of the fasted and re-fed mouse liver phosphoproteomes using lower pH reductive dimethylation. Methods 61(3):277-286.
16. Washburn MP, Wolters D, Yates JR, 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19(3): 242-247.
17. Hsu KL, et al. (2013) Development and optimization of piperidyl-1,2,3-triazole ureas as selective chemical probes of endocannabinoid biosynthesis. J Med Chem 56(21): 8257-8269.
18. Barnes CA (1979) Memory deficits associated with senescence: A neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 93(1):74-104.
19. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G (2006) XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78(3):779-787.
20. Hsu FF, Turk J (1999) Structural characterization of triacylglycerols as lithiated adducts by electrospray ionization mass spectrometry using low-energy collisionally activated dissociation on a triple stage quadrupole instrument. J Am Soc Mass Spectrom 10(7): 587-599.
21. Murphy RC, et al. (2007) Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal Biochem 366(1):59-70.
22. Haemmerle G, et al. (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312(5774):734-737.
23. Fujimoto T, Ohsaki Y, Suzuki M, Cheng J (2013) Imaging lipid droplets by electron microscopy. Methods Cell Biol 116:227-251.
24. Inoue H, et al. (2012) Roles of SAM and DDHD domains in mammalian intracellular phospholipase A1 KIAA0725p. Biochim Biophys Acta 1823(4):930-939.
25. Zimmermann R, et al. (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306(5700):1383-1386.
26. Zimmermann R, Lass A, Haemmerle G, Zechner R (2009) Fate of fat: The role of adipose triglyceride lipase in lipolysis. Biochim Biophys Acta 1791(6):494-500.
27. Fischer J, et al. (2007) The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 39(1):28-30.
28. Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R (2009) Neutral lipid storage disease: Genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab 297(2):E289-E296.
29. Etschmaier K, et al. (2011) Adipose triglyceride lipase affects triacylglycerol metabolism at brain barriers. J Neurochem 119(5):1016-1028.
30. Tani K, Mizoguchi T, Iwamatsu A, Hatsuzawa K, Tagaya M (1999) p125 is a novel mammalian Sec23p-interacting protein with structural similarity to phospholipidmodifying proteins. J Biol Chem 274(29):20505-20512.
31. Arrese EL, Patel RT, Soulages JL (2006) The main triglyceride-lipase from the insect fat body is an active phospholipase A(1): Identification and characterization. J Lipid Res 47(12):2656-2667.
32. Liguori R, et al. (2014) Impairment of brain and muscle energy metabolism detected by magnetic resonance spectroscopy in hereditary spastic paraparesis type 28 patients with DDHD1 mutations. J Neurol 261(9):1789-1793.
33. Mayer N, et al. (2013) Development of small-molecule inhibitors targeting adipose triglyceride lipase. Nat Chem Biol 9(12):785-787.
34. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV, Jr (2008) Thematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 49(11): 2283-2301.
35. Harris CA, et al. (2011) DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes. J Lipid Res 52(4):657-667.
36. Naik R, et al. (2014) Therapeutic strategies for metabolic diseases: Small-molecule diacylglycerol acyltransferase (DGAT) inhibitors. ChemMedChem, 10.1002/cmdc.201402069.
37. Blankman JL, Long JZ, Trauger SA, Siuzdak G, Cravatt BF (2013) ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci USA 110(4):1500-1505.